Artru F, Miquet X, Azahaf M et al (2020) Consequences of TIPSS placement on the body composition of patients with cirrhosis and severe portal hypertension: a large retrospective CT-based surveillance. Aliment Pharmacol Ther 52:1516–1526. https://doi.org/10.1111/apt.16080

Article  PubMed  Google Scholar 

Assaraf J, Weiss N, Thabut D (2017) Proton Pump Inhibitor Administration Triggers Encephalopathy in Cirrhotic patients by modulating blood–brain barrier drug transport. Gastroenterology 152:2077. https://doi.org/10.1053/j.gastro.2016.10.049

Article  CAS  PubMed  Google Scholar 

Azoulay D, Castaing D, Majno P et al (2001) Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 35:590–597. https://doi.org/10.1016/S0168-8278(01)00185-4

Article  CAS  PubMed  Google Scholar 

Bai M, Qi X, Yang Z et al (2011) Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. J Gastroenterol Hepatol 26:943–951. https://doi.org/10.1111/j.1440-1746.2011.06663.x

Article  PubMed  Google Scholar 

Bai M, He C, Yin Z et al (2014) Randomised clinical trial: l -ornithine- l -aspartate reduces significantly the increase of venous ammonia concentration after TIPSS. Aliment Pharmacol Ther 40:63–71. https://doi.org/10.1111/apt.12795

Article  CAS  PubMed  Google Scholar 

Bajaj JS, Saeian K, Schubert CM et al (2009) Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology 50:1175–1183. https://doi.org/10.1002/hep.23128

Article  PubMed  Google Scholar 

Bajaj JS, O’Leary JG, Tandon P et al (2017) Hepatic encephalopathy is Associated with mortality in patients with cirrhosis Independent of other extrahepatic organ failures. Clin Gastroenterol Hepatol 15:565–574e4. https://doi.org/10.1016/j.cgh.2016.09.157

Article  PubMed  Google Scholar 

Bañares R, Casado M, Rodríguez-Láiz JM et al (1998) Urgent Transjugular Intrahepatic Portosystemic Shunt for Control of Acute Variceal bleeding. Am J Gastroenterol 93:75–79. https://doi.org/10.1111/j.1572-0241.1998.075_c.x

Article  PubMed  Google Scholar 

Benmassaoud A, Roccarina D, Arico F et al (2020) Sarcopenia does not worsen survival in patients with cirrhosis undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory ascites. Am J Gastroenterol 115:1911–1914. https://doi.org/10.14309/ajg.0000000000000959

Article  PubMed  Google Scholar 

Berlioux P, Robic MA, Poirson H et al (2014) Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests: Hepatology, Vol. 00, No. 0, 2013. Hepatology 59:622–629. https://doi.org/10.1002/hep.26684

Bettinger D, Schultheiss M, Boettler T et al (2016) Procedural and shunt-related complications and mortality of the transjugular intrahepatic portosystemic shunt (TIPSS). Aliment Pharmacol Ther 44:1051–1061. https://doi.org/10.1111/apt.13809

Article  CAS  PubMed  Google Scholar 

Bischoff SC, Bernal W, Dasarathy S et al (2020) ESPEN practical guideline: clinical nutrition in liver disease. Clin Nutr 39:3533–3562. https://doi.org/10.1016/j.clnu.2020.09.001

Article  PubMed  Google Scholar 

Bouzbib C, Cluzel P, Sultanik P et al (2021) Prognosis of patients undergoing salvage TIPS is still poor in the preemptive TIPS era. Clin Res Hepatol Gastroenterol 45:101593. https://doi.org/10.1016/j.clinre.2020.101593

Article  CAS  PubMed  Google Scholar 

Bouzbib C, El Mourabit H, Wendum D et al (2022) ATP-binding cassette transporters expression in rats with cirrhosis and hepatic encephalopathy. Clin Res Hepatol Gastroenterol 46:101784. https://doi.org/10.1016/j.clinre.2021.101784

Article  CAS  PubMed  Google Scholar 

Bureau C, Garcia-Pagan JC, Otal P et al (2004) Improved clinical outcome using polytetrafluoroethylene-coated stents for tips: results of a randomized study. Gastroenterology 126:469–475. https://doi.org/10.1053/j.gastro.2003.11.016

Article  PubMed  Google Scholar 

Bureau C, Thabut D, Oberti F et al (2017) Transjugular Intrahepatic Portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites. Gastroenterology 152:157–163. https://doi.org/10.1053/j.gastro.2016.09.016

Article  PubMed  Google Scholar 

Bureau C, Thabut D, Jezequel C et al (2021) The Use of Rifaximin in the Prevention of overt hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt: a Randomized Controlled Trial. Ann Intern Med 174:633–640. https://doi.org/10.7326/M20-0202

Article  PubMed  Google Scholar 

Cabrera J, Maynar M, Granados R et al (1996) Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 110:832–839. https://doi.org/10.1053/gast.1996.v110.pm8608893

Article  CAS  PubMed  Google Scholar 

Chau TN, Patch D, Chan YW et al (1998) Salvage Transjugular Intrahepatic Portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 114:981–987. https://doi.org/10.1016/S0016-5085(98)00640-4

Article  CAS  PubMed  Google Scholar 

Cordoba J, Ventura-Cots M, Simón-Talero M et al (2014) Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). J Hepatol 60:275–281. https://doi.org/10.1016/j.jhep.2013.10.004

Article  PubMed  Google Scholar 

De Franchis R, Bosch J, Garcia-Tsao G et al (2022) Baveno VII– renewing consensus in portal hypertension. J Hepatol 76:959–974. https://doi.org/10.1016/j.jhep.2021.12.022

Article  PubMed  Google Scholar 

De Wit K, Schaapman JJ, Nevens F et al (2020) Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial). BMJ Open Gastroenterol 7:e000531. https://doi.org/10.1136/bmjgast-2020-000531

Article  PubMed  PubMed Central  Google Scholar 

Di Cola S, D’Amico G, Caraceni P et al (2024) Myosteatosis is closely associated with Sarcopenia and significantly worse outcomes in patients with cirrhosis. J Hepatol S0168827824003556. https://doi.org/10.1016/j.jhep.2024.05.020

Dunne PDJ, Sinha R, Stanley AJ et al (2020) Randomised clinical trial: standard of care versus early-transjugular intrahepatic porto‐systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding. Aliment Pharmacol Ther 52:98–106. https://doi.org/10.1111/apt.15797

Article  CAS  PubMed  Google Scholar 

Ehrenbauer AF, Schneider H, Stockhoff L et al (2023) Predicting overt hepatic encephalopathy after TIPS: value of three minimal hepatic encephalopathy tests. JHEP Rep 5:100829. https://doi.org/10.1016/j.jhepr.2023.100829

Article  PubMed  PubMed Central  Google Scholar 

Escorsell À, Bañares R, García-Pagán JC et al (2002) TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial: TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 35:385–392. https://doi.org/10.1053/jhep.2002.30418

Article  PubMed  Google Scholar 

Fanelli F, Salvatori FM, Rabuffi P et al (2009) Management of refractory hepatic Encephalopathy after insertion of TIPS: long-term results of Shunt Reduction with Hourglass-shaped balloon-expandable stent-graft. Am J Roentgenol 193:1696–1702. https://doi.org/10.2214/AJR.09.2968

Article  Google Scholar 

Gairing SJ, Mangini C, Zarantonello L et al (2024) Proton pump inhibitor use and risk of hepatic encephalopathy: a multicentre study. JHEP Rep 6:101104. https://doi.org/10.1016/j.jhepr.2024.101104

Article  PubMed  PubMed Central  Google Scholar 

Gangwani MK, Ahmed Z, Ishtiaq R et al (2023) Hepatic encephalopathy with proton pump inhibitor use in post tips patients: a systematic review and meta-analysis. Minerva Gastroenterol. https://doi.org/10.23736/S2724-5985.23.03422-8

Article  Google Scholar 

García-Pagán JC, Caca K, Bureau C et al (2010) Early Use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 362:2370–2379. https://doi.org/10.1056/NEJMoa0910102

Article  PubMed  Google Scholar 

García-Villarreal L, Martínez-Lagares F, Sierra A et al (1999) Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage: Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic Sclerotherapy for the Prevention of Variceal rebleeding after recent Variceal Hemorrha. Hepatology 29:27–32. https://doi.org/10.1002/hep.510290125

Article  PubMed